B. A. Seinstra

Technical Solutions to Ensure Safe Yttrium-90 Radioembolization in Patients With Initial Extrahepatic Deposition of 99mTechnetium–Albumin Macroaggregates

M. A. van den Bosch, H. Verkooijen, M. Lam, 2010, CardioVascular and Interventional Radiology.

Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients

M. A. van den Bosch, M. Lam, H. D. de Jong, 2017, EJNMMI Research.

Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?

M. A. van den Bosch, W. Mali, R. van Hillegersberg, 2010, Insights into imaging.

Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression.

K. Curran, R. Brentjens, Raymond Yeh, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

Intra-arterial radioembolization of breast cancer liver metastases: a structured review.

M. A. van den Bosch, J. Nijsen, M. Lam, 2013, European journal of pharmacology.

Trans-arterial (90)yttrium radioembolization for patients with unresectable tumors originating from the biliary tree.

M. A. van den Bosch, K. V. van Erpecum, M. Lam, 2011, Annals of hepatology.

Evolution of the Ablation Region After Magnetic Resonance–Guided High-Intensity Focused Ultrasound Ablation in a Vx2 Tumor Model

Marijn van Stralen, Paul J van Diest, Roel Deckers, 2013, Investigative radiology.

Transarterial RAdioembolization versus ChemoEmbolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial

M. A. van den Bosch, H. Van Vlierberghe, H. Verkooijen, 2012, Trials.

Abstract No. 377: Transarterial RAdioembolization versus ChemoEmbolization for the treatment of HCC: TRACE trial-an international multicenter randomized controlled trial

M. A. Bosch, B. Hoek, I. Younis, 2012 .